Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES BELLBOX IN CONJUNCTION WITH MERGER WITH LYKO
Mandate

VINGE ADVISES BELLBOX IN CONJUNCTION WITH MERGER WITH LYKO

November 26, 2014

Vinge has advised Bellbox in conjunction with the merger with Lyko. The merger has created a Nordic region leader within professional haircare and beauty products. The combined group is expected to have a turnover of approximately SEK 500 million and the merger has created a multi-channel retailer with Bellbox’s store network, which consists of 30 wholly owned stores in Sweden and Norway, and Lyko.se, a destination for beauty products online.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Alex Miler and Maria Dahlin. Louise Brorson Salomon provided financing advice.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026